ABIONYX Pharma announced that following the Board of Directors meeting held on 6 September 2019, Cyrille TUPIN, Deputy CEO of the company since December 2018, was appointed CEO. Cyrille Tupin succeeds Richard Pasternak, and Mr. Tupin becomes a director of the company, replacing Michael H. Davidson who is resigning as a director.